Document Detail


Granulocyte transfusion: current status.
MedLine Citation:
PMID:  17198843     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Infection associated with therapy-related neutropenia continues to be a major cause of morbidity and mortality. Renewed interest in granulocyte transfusion therapy as treatment for this condition has been generated by the observation that large doses of granulocytes can be obtained from donors who have been stimulated with granulocyte colony-stimulating factor (G-CSF). Granulocytes collected from these donors have been shown to effectively raise the patient's neutrophil count and appear to function normally as judged both by in vitro and in vivo measures. The evidence for clinical efficacy is limited to that of case reports and small series, and the results are not uniform. Randomized controlled clinical trials are needed to determine whether this therapy is useful in either clearing infections or prolonging survival.
Authors:
Thomas H Price
Related Documents :
3165683 - Incidence of symptoms and aids in 146 swedish haemophiliacs and blood transfusion recip...
8693513 - Acute gram-negative urosepsis mimicking an acute hemolytic transfusion reaction.
10403743 - High prevalence of anti-hepatitis b virus serological markers in patients with hepatiti...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in hematology     Volume:  44     ISSN:  0037-1963     ISO Abbreviation:  Semin. Hematol.     Publication Date:  2007 Jan 
Date Detail:
Created Date:  2007-01-02     Completed Date:  2007-02-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0404514     Medline TA:  Semin Hematol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  15-23     Citation Subset:  IM    
Affiliation:
Puget Sound Blood Center and Department of Medicine, University of Washington, Seattle, WA 98104, USA. thprice@psbc.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Case-Control Studies
Granulocyte Colony-Stimulating Factor / therapeutic use*
Granulocytes
Humans
Leukapheresis / methods*
Leukocyte Transfusion / adverse effects*
Treatment Outcome
Chemical
Reg. No./Substance:
143011-72-7/Granulocyte Colony-Stimulating Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary transfusion reactions.
Next Document:  Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured ...